Sekundäre Diabetesformen

  • B. H. Ludvik
Chapter

Zusammenfassung

Der sekundäre Diabetes mellitus kann im Rahmen von Erkrankungen des Pankreas, von Endokrinopathien, Mutationen des Insulingens oder Störungen des Insulinrezeptors entstehen und zudem durch die Verabreichung verschiedener Medikamente ausgelöst werden. Mit Ausnahme der Substanzdefekte im Bereich des Pankreas und der Mutationen des Insulingens bzw. -rezeptors sind diese Formen nach Wegfall des auslösenden Agens reversibel — es sei denn, es wurde damit eine Prädisposition für die Entstehung eines Diabetes mellitus Typ 2 demaskiert.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Björntorp P (1993) Hyperandrogenicity in women-a prediabetic condition? J Intern Med 234:579–583PubMedCrossRefGoogle Scholar
  2. Dunaif A (1997) Insulin resistance and the polycystic ovary Syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800PubMedGoogle Scholar
  3. Gifford RW, Kuale WF, Mahler FT (1964) Clinical features, diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 39:281PubMedGoogle Scholar
  4. Gress TW, Nieto FJ, Shahar E et al (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 342:905–912PubMedCrossRefGoogle Scholar
  5. Gurwitz JH, Bohn RL, Glynn RJ et al (1994) Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 154:97–101PubMedCrossRefGoogle Scholar
  6. Hansen I, Tsalikian E, Beaufrere B et al (1986) Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 250: E269–273PubMedGoogle Scholar
  7. Helderman JH, Elahi D, Andersen DK et al (1983) Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32:106–111PubMedCrossRefGoogle Scholar
  8. Holstein A, Plaschke A, Egberts EH (2001) Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection. Exp Clin Endocrinol Diabetes 109: 389–392PubMedCrossRefGoogle Scholar
  9. Klein S, Jahoor F, Baba H et al (1992) In vivo assessment of the metabolic alterations in glucagonoma Syndrome. Metabolism 41:1171–1175PubMedCrossRefGoogle Scholar
  10. Komiya I, Takasu N, Yamada T et al (1992) Studies on the association of NIDDM in Japanese patients with hyperthyroid Graves’ disease. Horm Res 38:264–268PubMedCrossRefGoogle Scholar
  11. Lanng S (2001) Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2:253–259PubMedCrossRefGoogle Scholar
  12. Liebzeit KA, Markowitz JS, Caley CF (2001) New onset diabetes and atypical antipsychotics. Eur Neuropsychopharmacol 11:25–32PubMedCrossRefGoogle Scholar
  13. Oral AE, Simha V, Ruiz E et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570–578PubMedCrossRefGoogle Scholar
  14. Ost L, Tyden G, Fehrman I (1988) Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation 46:370–372PubMedCrossRefGoogle Scholar
  15. Raue G, Keim V (1999) Secondary diabetes in chronic pancreati-tis. Z Gastroenterol (Suppl 1):4–9PubMedGoogle Scholar
  16. Salonen JT, Tuomainen TP, Nyssonen K et al (1998) Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 317:727PubMedCentralPubMedCrossRefGoogle Scholar
  17. Shamoon H, Soman V, Sherwin RS (1980) The influence of acute physiological increments of Cortisol on fuel metabolism and insulin binding to monocytes in normal humans. J Clin Endocrinol Metab 50:495–501PubMedCrossRefGoogle Scholar
  18. Slezak LA, Andersen DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460PubMedCrossRefGoogle Scholar
  19. Tripathy BB, Samal KC (1997) Overview and consensus Statement on diabetes in tropical areas. Diabetes Metab Rev 13:63–76PubMedCrossRefGoogle Scholar
  20. Van den Ouweland JM, Lemkes HH, Ruitenbeek W et al (1992) Mutation in mitochondrial tRNA(Leu) (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368–371PubMedCrossRefGoogle Scholar
  21. Witte DL, Crosby WH, Edwards CQ et al (1996) Practice guide-line development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 245:139–200PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • B. H. Ludvik

There are no affiliations available

Personalised recommendations